Recent advances in polymeric core–shell nanocarriers for targeted delivery of chemotherapeutic drugs
Authors:
- 1 October 2021
- journal article
- review article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 608, 121094
Abstract
No abstract availableKeywords
Funding Information
- Program of Shanghai Academic Research Leader (19XD1423700)
- Natural Science Foundation of Shanghai Municipality (19ZR1444200)
- National Natural Science Foundation of China (81873198)
This publication has 131 references indexed in Scilit:
- Biodegradable cationic nanoparticles loaded with an anticancer drug for deep penetration of heterogeneous tumoursBiomaterials, 2013
- c(RGDfK) decorated micellar drug delivery system for intravesical instilled chemotherapy of superficial bladder cancerJournal of Controlled Release, 2013
- Poly(ethylene glycol)-block-poly(ε-caprolactone) micelles for combination drug delivery: Evaluation of paclitaxel, cyclopamine and gossypol in intraperitoneal xenograft models of ovarian cancerJournal of Controlled Release, 2013
- The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micellesBiomaterials, 2012
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticlesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2009
- Polyethylene glycol–phosphatidylethanolamine conjugate (PEG–PE)-based mixed micelles: Some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated effluxInternational Journal of Pharmaceutics, 2006
- Phase 1 Study of Weekly Polyethylene Glycol-Camptothecin in Patients with Advanced Solid Tumors and LymphomasClinical Cancer Research, 2005
- Micelles from Poly(ethylene glycol)–Phosphatidyl Ethanolamine Conjugates (Peg-Pe) as Pharmaceutical Nanocarriers for Poorly Soluble Drug CamptothecinJournal of Biomedical Nanotechnology, 2005
- Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final reportLung Cancer, 2004